Frontlight ResearchEarly access
Not yet taking people in United StatesNo phase
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
Key facts
- Who runs it
- Microbio Co Ltd
- Where
- Albuquerque, Baltimore, Houston, Indianapolis, and Nashville, United StatesSee the 5 sitesAlso in 2 other countries, 3 sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 1,500 people, planned
- Started
- Nov 2026
- Expected to end
- Jan 2028
- Type of study
- Observational
- Treatments tested
- InfectID-BSI (Bloodstream Infection) qPCR Assay
- Record updated
- 8 October 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Male or female of neonates (less than 1 month of age), paediatrics (between 1 month and 17 years of age) or adults (≥18 years of age)
- Admitted to ICU, Emergency Department, or other medical wards for acute illness with medical decision to perform blood culture for suspicion of bloodstream Infection
- Two additional EDTA blood sample/s collected from one anatomical site and at the same time as blood culture (two EDTA samples to be collected where possible)
- EDTA blood volume is ≥1mL
- EDTA blood sample is stored according to Microbio's stability requirements
Who cannot take part
- Subject has had an antimicrobial drug administered through the same port or central line as is used to collect the specimen
- No suspicion of blood stream infection (BSI)
- Any inclusion criterion not met
- Multiple EDTA blood samples from the same patient
- EDTA blood sample not obtained from the same anatomical site and at the same time as the blood culture sample
- EDTA blood samples that have not been stored according to Microbio's sample stability requirements
- EDTA blood volume <1mL
Where in United States
Also in 2 other countries, 3 sites
- TriCore Reference LaboratoriesAlbuquerque, United StatesContact: Naomi DeFazioNot yet recruiting
- University of MarylandBaltimore, United StatesContact: Naomi DeFazioNot yet recruiting
- Texas Children's HospitalHouston, United StatesContact: Naomi DeFazioNot yet recruiting
- Indiana University HospitalIndianapolis, United StatesContact: Naomi DeFazioNot yet recruiting
- Vanderbilt University Medical CentreNashville, United StatesContact: Naomi DeFazioNot yet recruiting
About the trial
What the trial wants to find out
The objective of the study is to determine the efficacy of the Microbio InfectID-BSI qPCR kit in a clinical laboratory environment using patient whole blood for pathogen detection and identification versus standard of care methods from blood culture.
Read full original descriptionShow less
The objective of this study is to determine the sensitivity and specificity of the Microbio InfectID-BSI qPCR kit by the evaluation of clinical blood samples versus standard of care methods from blood culture.
Treatments tested
- InfectID-BSI (Bloodstream Infection) qPCR Assay
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast
- Record updated
- 8 October 2026